Alan F. List
Q Therapeutics (United States)(US)ManRos Therapeutics (France)(FR)Praxis BioSciences (United States)(US)Precision BioSciences (United States)(US)IsoPlexis (United States)(US)Alpha Environmental (United States)(US)University of Tampa(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study(2009)2,624 cited
- → Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion(2006)1,313 cited
- → Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.(1997)1,257 cited
- → Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia(2009)953 cited
- → Efficacy of Lenalidomide in Myelodysplastic Syndromes(2005)873 cited
- → Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs(2008)654 cited